Sabra Healthcare REIT (NASDAQ:SBRA) Now Covered by Barclays

Research analysts at Barclays began coverage on shares of Sabra Healthcare REIT (NASDAQ:SBRA) in a report released on Tuesday,Benzinga reports. The firm set an “equal weight” rating and a $21.00 price target on the real estate investment trust’s stock. Barclays‘s target price points to a potential upside of 6.44% from the stock’s previous close.

SBRA has been the subject of a number of other research reports. UBS Group set a $19.00 price target on shares of Sabra Healthcare REIT in a report on Thursday, June 18th. Truist Financial upped their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a research report on Friday, March 13th. Wells Fargo & Company raised their target price on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research report on Monday, June 1st. Cantor Fitzgerald lifted their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Finally, Raymond James Financial assumed coverage on Sabra Healthcare REIT in a research note on Wednesday, June 17th. They set an “underperform” rating for the company. Four research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $21.27.

Sabra Healthcare REIT Trading Down 2.1%

SBRA stock opened at $19.73 on Tuesday. The firm’s 50-day moving average is $19.71 and its 200 day moving average is $19.68. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. Sabra Healthcare REIT has a 12 month low of $17.17 and a 12 month high of $21.28. The company has a market capitalization of $4.98 billion, a PE ratio of 31.32, a P/E/G ratio of 1.50 and a beta of 0.65.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.16. The company had revenue of $211.74 million during the quarter, compared to analyst estimates of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The firm’s revenue for the quarter was up 20.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, research analysts anticipate that Sabra Healthcare REIT will post 1.5 EPS for the current year.

Hedge Funds Weigh In On Sabra Healthcare REIT

Several large investors have recently bought and sold shares of the business. Principal Financial Group Inc. lifted its position in shares of Sabra Healthcare REIT by 21.6% during the 4th quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock worth $472,617,000 after buying an additional 4,431,897 shares during the last quarter. Bank of Montreal Can grew its holdings in shares of Sabra Healthcare REIT by 8.2% during the third quarter. Bank of Montreal Can now owns 2,787,655 shares of the real estate investment trust’s stock worth $51,962,000 after buying an additional 211,686 shares during the last quarter. Legal & General Group Plc increased its holdings in shares of Sabra Healthcare REIT by 16.5% in the fourth quarter. Legal & General Group Plc now owns 1,427,180 shares of the real estate investment trust’s stock valued at $27,031,000 after purchasing an additional 201,667 shares during the period. UBS Group AG increased its stake in Sabra Healthcare REIT by 143.1% in the 4th quarter. UBS Group AG now owns 1,460,219 shares of the real estate investment trust’s stock valued at $27,657,000 after buying an additional 859,584 shares during the period. Finally, Advisors Capital Management LLC increased its stake in shares of Sabra Healthcare REIT by 3.2% during the fourth quarter. Advisors Capital Management LLC now owns 2,382,935 shares of the real estate investment trust’s stock worth $45,133,000 after acquiring an additional 73,281 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.